Cited by 68Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatmentsGenetic Associations and Epidemiology

African ancestry GWAS of dementia in a large military cohort identifies significant risk loci

Open access
Sherva, Richard, Zhang, Rui, Sahelijo, Nathan, Jun, Gyungah, Anglin, Tori, Chanfreau, Catherine, Cho, Kelly, Fonda, Jennifer R. +20 more·2023·Molecular Psychiatry

Published version of a preprint

Abstract

While genome wide association studies (GWASs) of Alzheimer's Disease (AD) in European (EUR) ancestry cohorts have identified approximately 83 potentially independent AD risk loci, progress in non-European populations has lagged. In this study, data from the Million Veteran Program (MVP), a biobank which includes genetic data from more than 650,000 US Veteran participants, was used to examine dementia genetics in an African descent (AFR) cohort. A GWAS of Alzheimer's disease and related dementias (ADRD), an expanded AD phenotype including dementias such as vascular and non-specific dementia that included 4012 cases and 18,435 controls age 60+ in AFR MVP participants was performed. A proxy dementia GWAS based on survey-reported parental AD or dementia (n = 4385 maternal cases, 2256 paternal cases, and 45,970 controls) was also performed. These two GWASs were meta-analyzed, and then subsequently compared and meta-analyzed with the results from a previous AFR AD GWAS from the Alzheimer's Disease Genetics Consortium (ADGC). A meta-analysis of common variants across the MVP ADRD and proxy GWASs yielded GWAS significant associations in the region of APOE (p = 2.48 × 10-101), in ROBO1 (rs11919682, p = 1.63 × 10-8), and RNA RP11-340A13.2 (rs148433063, p = 8.56 × 10-9). The MVP/ADGC meta-analysis yielded additional significant SNPs near known AD risk genes TREM2 (rs73427293, p = 2.95 × 10-9), CD2AP (rs7738720, p = 1.14 × 10-9), and ABCA7 (rs73505251, p = 3.26 × 10-10), although the peak variants observed in these genes differed from those previously reported in EUR and AFR cohorts. Of the genes in or near suggestive or genome-wide significant associated variants, nine (CDA, SH2D5, DCBLD1, EML6, GOPC, ABCA7, ROS1, TMCO4, and TREM2) were differentially expressed in the brains of AD cases and controls. This represents the largest AFR GWAS of AD and dementia, finding non-APOE GWAS-significant common SNPs associated with dementia. Increasing representation of AFR participants is an important priority in genetic studies and may lead to increased insight into AD pathophysiology and reduce health disparities.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41380-022-01890-3

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

1 retracted

Flagged first, then by citations

Research works printed but not linked: 47

  1. [1]2020 Alzheimer’s disease facts and figures. Alzheimers Dement 2020. 32157811
  2. [4]Barnes LL. Alzheimer disease in African American individuals: increased incidence or not enough data? Nat Rev Neurol 2022; 18(1): 56– 62. 34873310 PMC8647782
  3. [5]Clark LR, Norton D, Berman SE, Johnson SC, Bendlin BB, Wieben O Association of Cardiovascular and Alzheimer’s Disease Risk Factors with Intracranial Arterial Blood Flow in Whites and African Americans. J Alzheimers Dis 2019; 72(3): 919– 929. 31658057 PMC7081660
  4. [6]Yaffe K, Falvey C Fau - Harris TB, Harris Tb Fau - Newman A, Newman A Fau - Satterfield S, Satterfield S Fau - Koster A, Koster A Fau - Ayonayon H Effect of socioeconomic disparities on incidence of dementia among biracial older adults: prospective study. BMJ 2013; 347: f7051. 24355614 PMC3898154
  5. [8]Kunkle BW, Grenier-Boley B, Sims R, Bis JC, Damotte V, Naj AC Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Abeta, tau, immunity and lipid processing. Nat Genet 2019; 51(3): 414– 430. 30820047 PMC6463297
  6. [10]Bellenguez C, Kucukali F, Jansen IE, Kleineidam L, Moreno-Grau S, Amin N New insights into the genetic etiology of Alzheimer’s disease and related dementias. Nat Genet 2022. PMC9005347 35379992
  7. [11]Jun GR, Chung J, Mez J, Barber R, Beecham GW, Bennett DA Transethnic genome-wide scan identifies novel Alzheimer’s disease loci. Alzheimers Dement 2017; 13(7): 727– 738. 28183528 PMC5496797
  8. [12]Kunkle BW, Schmidt M, Klein HU, Naj AC, Hamilton-Nelson KL, Larson EB Novel Alzheimer Disease Risk Loci and Pathways in African American Individuals Using the African Genome Resources Panel: A Meta-analysis. JAMA Neurol 2021; 78(1): 102– 113. 33074286 PMC7573798
  9. [13]Logue MW, Schu M, Vardarajan BN, Buros J, Green RC, Go RC A comprehensive genetic association study of Alzheimer disease in African Americans. Arch Neurol 2011; 68(12): 1569– 1579. 22159054 PMC3356921
  10. [14]Mez J, Chung J, Jun G, Kriegel J, Bourlas AP, Sherva R Two novel loci, COBL and SLC10A2, for Alzheimer’s disease in African Americans. Alzheimers Dement 2017; 13(2): 119– 129. 27770636 PMC5318231
  11. [15]Reitz C, Jun G, Naj A, Rajbhandary R, Vardarajan BN, Wang LS Variants in the ATP-binding cassette transporter (ABCA7), apolipoprotein E 4,and the risk of late-onset Alzheimer disease in African Americans. Jama 2013; 309(14): 1483– 1492. 23571587 PMC3667653
  12. [16]Logue MW, Lancour D, Farrell J, Simkina I, Fallin MD, Lunetta KL Targeted Sequencing of Alzheimer Disease Genes in African Americans Implicates Novel Risk Variants. Front Neurosci 2018; 12: 592. 30210277 PMC6119822
  13. [17]Ikezu T, Chen C, DeLeo AM, Zeldich E, Fallin MD, Kanaan NM Tau Phosphorylation is Impacted by Rare AKAP9 Mutations Associated with Alzheimer Disease in African Americans. Journal of Neuroimmune Pharmacology 2018; 13(2): 254– 264. 29516269 PMC5928172
  14. [18]Logue MW, Schu M, Vardarajan BN, Farrell J, Bennett DA, Buxbaum JD Two rare AKAP9 variants are associated with Alzheimer’s disease in African Americans. Alzheimer’s & Dementia 2014; 10(6): 609– 618.e611. PMC4253055 25172201
  15. [19]Jansen IE, Savage JE, Watanabe K, Bryois J, Williams DM, Steinberg S Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer’s disease risk. Nat Genet 2019; 51(3): 404– 413. 30617256 PMC6836675
  16. [20]Fang H, Hui Q, Lynch J, Honerlaw J, Assimes TL, Huang J Harmonizing Genetic Ancestry and Self-identified Race/Ethnicity in Genome-wide Association Studies. Am J Hum Genet 2019; 105(4): 763– 772. 31564439 PMC6817526
  17. [21]Cho K, Gagnon DR, Driver JA, Altincatal A, Kosik N, Lanes S Dementia Coding, Workup, and Treatment in the VA New England Healthcare System. Int J Alzheimers Dis 2014; 2014: 821894. PMC3950831 24701364
  18. [23]Hunter-Zinck H, Shi Y, Li M, Gorman BR, Ji SG, Sun N Genotyping Array Design and Data Quality Control in the Million Veteran Program. Am, J Hum Genet; 106(4): 535– 548. 32243820 PMC7118558
  19. [24]Abraham G, Qiu Y, Inouye M. FlashPCA2: principal component analysis of Biobank-scale genotype datasets. Bioinformatics 2017; 33(17): 2776– 2778. 28475694
  20. [25]Wang X. Firth logistic regression for rare variant association tests. Front Genet 2014; 5: 187. 24995013 PMC4063169
  21. [26]Willer CJ, Li Y, Abecasis GR. METAL: fast and efficient meta-analysis of genomewide association scans. Bioinformatics 2010; 26(17): 2190– 2191. 20616382 PMC2922887
  22. [27]Watanabe K, Taskesen E, van Bochoven A, Posthuma D. Functional mapping and annotation of genetic associations with FUMA. Nat Commun 2017; 8(1): 1826. 29184056 PMC5705698
  23. [29]Panitch R, Hu J, Chung J, Zhu C, Meng G, Xia W Integrative brain transcriptome analysis links complement component 4 and HSPA2 to the APOE ε2 protective effect in Alzheimer disease. Molecular Psychiatry 2021. PMC8758485 34480088
  24. [30]de Klein N, Tsai EA, Vochteloo M, Baird D, Huang Y, Chen C-Y Brain expression quantitative trait locus and network analysis reveals downstream effects and putative drivers for brain-related diseases. bioRxiv 2021: 2021.2003.2001.433439. PMC10011140 36823318
  25. [31]1000 Genomes Project Consortium, Auton A, Brooks LD, Durbin RM, Garrison EP, Kang HM A global reference for human genetic variation. Nature 2015; 526(7571): 68– 74. 26432245 PMC4750478
  26. [32]Alexander DH, Novembre J, Lange K. Fast model-based estimation of ancestry in unrelated individuals. Genome Res 2009; 19(9): 1655– 1664. 19648217 PMC2752134
  27. [33]Rogaeva E, Meng Y, Lee JH, Gu Y, Kawarai T, Zou F The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease. Nat Genet 2007; 39(2): 168– 177. 17220890 PMC2657343
  28. [36]Mills MC, Rahal C. A scientometric review of genome-wide association studies. Commun Biol 2019; 2: 9. 30623105 PMC6323052
  29. [37]Sirugo G, Williams SM, Tishkoff SA. The Missing Diversity in Human Genetic Studies. Cell 2019; 177(4): 1080. 31051100
  30. [39]Farrer LA, Cupples LA, Haines JL, Hyman B, Kukull WA, Mayeux R Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. Jama 1997; 278(16): 1349– 1356. 9343467
  31. [40]Choi YY, Lee JJ, Choi KY, Seo EH, Choo IH, Kim H The Aging Slopes of Brain Structures Vary by Ethnicity and Sex: Evidence From a Large Magnetic Resonance Imaging Dataset From a Single Scanner of Cognitively Healthy Elderly People in Korea. Front Aging Neurosci 2020; 12: 233. 32903525 PMC7437271
  32. [41]Kidd T, Brose K, Mitchell KJ, Fetter RD, Tessier-Lavigne M, Goodman CS Roundabout controls axon crossing of the CNS midline and defines a novel subfamily of evolutionarily conserved guidance receptors. Cell 1998; 92(2): 205– 215. 9458045
  33. [42]Andrews WD, Barber M, Parnavelas JG. Slit-Robo interactions during cortical development. J Anat 2007; 211(2): 188– 198. 17553100 PMC2375773
  34. [43]Sasaki T, Komatsu Y, Yamamori T. Expression patterns of SLIT/ROBO mRNAs reveal a characteristic feature in the entorhinal-hippocampal area of macaque monkeys. BMC Research Notes 2020; 13(1): 262. 32460877 PMC7251749
  35. [44]Wang B, Li H, Mutlu SA, Bowser DA, Moore MJ, Wang MC The Amyloid Precursor Protein Is a Conserved Receptor for Slit to Mediate Axon Guidance. eNeuro 2017; 4(3). PMC5534435 28785723
  36. [45]Bai G, Chivatakarn O, Bonanomi D, Lettieri K, Franco L, Xia C Presenilin-Dependent Receptor Processing Is Required for Axon Guidance. Cell 2011; 144(1): 106– 118. 21215373 PMC3034090
  37. [46]Prokopenko D, Morgan SL, Mullin K, Hofmann O, Chapman B, Kirchner R Whole-genome sequencing reveals new Alzheimer’s disease-associated rare variants in loci related to synaptic function and neuronal development. Alzheimers Dement 2021; 17(9): 1509– 1527. 33797837 PMC8519060
  38. [47]Moskovitz J, Bar-Noy S, Williams WM, Requena J, Berlett BS, Stadtman ER. Methionine sulfoxide reductase (MsrA) is a regulator of antioxidant defense and lifespan in mammals. Proc Natl Acad Sci U S A 2001; 98(23): 12920– 12925. 11606777 PMC60800
  39. [48]Kwon YJ, Kim JO, Park JM, Choi JE, Park DH, Song Y Identification of Genetic Factors Underlying the Association between Sodium Intake Habits and Hypertension Risk. Nutrients 2020; 12(9). PMC7551216 32854392
  40. [49]Kuhn K, Bertling WM, Emmrich F. Cloning of a functional cDNA for human cytidine deaminase (CDD) and its use as a marker of monocyte/macrophage differentiation. Biochem Biophys Res Commun 1993; 190(1): 1– 7. 8422236
  41. [50]Gray EJ, Petsalaki E, James DA, Bagshaw RD, Stacey MM, Rocks O Src homology 2 domain containing protein 5 (SH2D5) binds the breakpoint cluster region protein, BCR, and regulates levels of Rac1-GTP. J Biol Chem 2014; 289(51): 35397– 35408. 25331951 PMC4271225
  42. [51]Joubert PE, Meiffren G, Gregoire IP, Pontini G, Richetta C, Flacher M Autophagy induction by the pathogen receptor CD46. Cell Host Microbe 2009; 6(4): 354– 366. 19837375
  43. [52]Pickford F, Masliah E, Britschgi M, Lucin K, Narasimhan R, Jaeger PA The autophagy-related protein beclin 1 shows reduced expression in early Alzheimer disease and regulates amyloid beta accumulation in mice. J Clin Invest 2008; 118(6): 2190– 2199. 18497889 PMC2391284
  44. [53]Cardone J, Le Friec G, Kemper C. CD46 in innate and adaptive immunity: an update. Clin Exp Immunol 2011; 164(3): 301– 311. 21488871 PMC3087925
  45. [54]Weyand NJ, Calton CM, Higashi DL, Kanack KJ, So M. Presenilin/gamma-secretase cleaves CD46 in response to Neisseria infection. J Immunol 2010; 184(2): 694– 701. 20018629 PMC5141583
  46. [56]Jounai N, Kobiyama K, Shiina M, Ogata K, Ishii KJ, Takeshita F. NLRP4 negatively regulates autophagic processes through an association with beclin1. J Immunol 2011; 186(3): 1646– 1655. 21209283
  47. [57]Nelson KM. The burden of obesity among a national probability sample of veterans. J Gen Intern Med 2006; 21(9): 915– 919 16918734 PMC1831589

Cited by

Sorted by citations

Authors
Sherva, R., Zhang, R., Sahelijo, N., Jun, G., Anglin, T., Chanfreau, C., Cho, K., Fonda, J. R., Gaziano, J. M., Harrington, K. M., Ho, Y.-L., Kremen, W. S., Litkowski, E., Lynch, J., Neale, Z., Roussos, P., Marra, D., Mez, J., Miller, M. W., Salat, D. H., Tsuang, D., Wolf, E., Zeng, Q., Panizzon, M. S., Merritt, V. C., Farrer, L. A., Hauger, R. L., & Logue, M. W.
Affiliations
  • Boston University (US)
  • VA Boston Healthcare System (US)
  • Brigham and Women's Hospital (US)
  • University of California San Diego (US)
  • VA Eastern Colorado Health Care System (US)
  • Nathan Kline Institute for Psychiatric Research (US)
  • VA Puget Sound Health Care System (US)
  • Washington DC VA Medical Center (US)
Corresponding author
Logue, Mark W.
Venue
Molecular Psychiatry
Published
2022-12-22
Volume
28
Issue
3
Pages
1293-1302
ISSN
  • 1359-4184 (ISSN-L)
  • 1476-5578
OpenAlex
W4312128743
Cited by
68
References
11
Citations by year
2026: 13 · 2025: 20 · 2024: 20 · 2023: 14 · 2022: 1
FWCI
2.32
Type
journal article
Language
en
Open access
Locations
  • Molecular Psychiatry (publishedVersion)
  • medRxiv (acceptedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • U.S. Department of Veterans Affairs (I01 BX004192, IK2 CX002192, I01 CX001727)
  • Office of Research and Development
  • National Institute on Aging (R01AG064955, U01AG032984, R01AG050595, R01AG076838)
  • National Institute of Mental Health (T32MH019836)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
Keywords
Alzheimer's disease, dementia, African ancestry, Alzheimer's disease and related dementias, genetic susceptibility loci, apolipoprotein E, ROBO1, TREM2, CD2AP, ABCA7, Million Veteran Program, military veterans, genetic variants, non-European populations, vascular dementia, gene-environment interaction
MeSH terms
Aged, Alzheimer Disease, Black or African American, Dementia, Genotype, Humans, Middle Aged, Military Personnel, Polymorphism, Genetic, United States, Genetic Predisposition to Disease, Gene Expression Profiling, Databases, Genetic, Genome-Wide Association Study

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review